In response to the COVID-19 pandemic, Arctoris accelerated the onboarding and validation - in under 24 hours - of three critical assays, which measure key target functions responsible for viral processing, infectivity and transmission.
In this webinar Dr Daniel Thomas, Head of Discovery Biology, Arctoris discusses the advantages of automated experimental and analytical workflows together with COVID case study examples highlighting the quality of data attainable.
Catherine Wark, Applications Manager, BMG LABTECH UK also looks at innovative microplate readers designed for drug discovery.
What you will learn:
- How researchers can benefit from automation and liquid handling, in particular, sensitive and robust plate reader capabilities.
- How this data is enabling researchers around the world to rapidly test hypotheses and evaluate new molecules.
- How this enhances the quality and pace of decision-making as well as confidence in the outcomes, all at a time of unprecedented global need.
